Living with a RET gene mutation: patient perspectives

Area of Science:

• Endocrinology
• Genetics
• Oncology

Background:

• Multiple endocrine neoplasia type 2 (MEN2) comprises autosomal dominant inherited neuroendocrine neoplasm syndromes, MEN2A and MEN2B (MEN3).
• MEN2 is characterized by medullary thyroid cancer (MTC) and phaeochromocytoma, with specific genotypes correlating to additional conditions.
• MEN2A includes parathyroid hyperplasia, while MEN2B involves intestinal ganglioneuromatosis, mucosal neuromas, and musculoskeletal abnormalities.

Purpose of the Study:

• To review case studies illustrating the benefits and obstacles of RET testing for MEN2A and MEN2B diagnosis.
• To emphasize the importance of expert care for MEN2 patients due to atypical presentations.
• To highlight the need for research into the psychosocial impact of MEN2.

Main Methods:

• Mini-review of four case studies (two MEN2A, two MEN2B).
• Analysis of diagnostic challenges and genotype/phenotype correlations.
• Inclusion of patient/parent perspectives on living with MEN2.

Main Results:

• RET testing offers advantages in diagnosing MEN2A and MEN2B.
• Obstacles to diagnosis persist despite improved genotype/phenotype correlations.
• Atypical cases necessitate specialized care centers.

Conclusions:

• Expert management is crucial for MEN2 patients, even with typical presentations.
• Further research is needed on the psychosocial effects of these hereditary endocrine neoplasia syndromes.
• Early and accurate diagnosis through genetic testing is vital for effective management of MEN2.